Skip to Content

UK Edition. Click here for US version.

LAMICTAL 50MG DISPERSIBLE/ CHEWABLE TABLETS

Active substance(s): LAMOTRIGINE / LAMOTRIGINE / LAMOTRIGINE

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

Package Leaflet: Information for the User

Lamictal® 50 mg, 200 mg chewable/dispersible tablets
lamotrigine

Lamictal®
50 mg, 200 mg chewable/dispersible tablets

lamotrigine
Read all of this leaflet carefully before you start taking this medicine because it contains important
information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their
signs of illness are the same as yours.
If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.

What is in this leaflet
1
2
3
4
5
6

What Lamictal is and what it is used for
What you need to know before you take Lamictal
How to take Lamictal
Possible side effects
How to store Lamictal
Contents of the pack and other information

Other formats
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only)
Please be ready to give the following information:
Product name

Lamictal 50 mg chewable/dispersible tablets
Lamictal 200 mg chewable/dispersible tablets

Reference number

00003/0368

This is a service provided by the Royal National Institute of Blind People.

1

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

1 What Lamictal is and what it is used for
Lamictal belongs to a group of medicines called anti-epileptics. It is used to treat two conditions - epilepsy
and bipolar disorder.
Lamictal treats epilepsy by blocking the signals in the brain that trigger epileptic seizures (fits).
• For adults and children aged 13 years and over, Lamictal can be used on its own or with other
medicines, to treat epilepsy. Lamictal can also be used with other medicines to treat the seizures that
occur with a condition called Lennox-Gastaut syndrome.
• For children aged between 2 and 12 years, Lamictal can be used with other medicines, to treat those
conditions. It can be used on its own to treat a type of epilepsy called typical absence seizures.
Lamictal also treats bipolar disorder.
People with bipolar disorder (sometimes called manic depression) have extreme mood swings, with periods
of mania (excitement or euphoria) alternating with periods of depression (deep sadness or despair). For
adults aged 18 years and over, Lamictal can be used on its own or with other medicines, to prevent the
periods of depression that occur in bipolar disorder. It is not yet known how Lamictal works in the brain to
have this effect.

2 What you need to know before you take Lamictal
Do not take Lamictal:


if you are allergic (hypersensitive) to lamotrigine or any of the other ingredients of this medicine (listed
in Section 6).

If this applies to you:
 Tell your doctor and don’t take Lamictal.

Take special care with Lamictal
Talk to your doctor or pharmacist before taking Lamictal:
• if you have any kidney problems
• if you have ever developed a rash after taking lamotrigine or other medicines for bipolar disorder or
epilepsy
• if you have ever developed meningitis after taking lamotrigine (read the description of these
symptoms in Section 4 of this leaflet: Rare side effects)
• if you are already taking medicine that contains lamotrigine.
If any of these applies to you:
 Tell your doctor, who may decide to lower the dose or that Lamictal is not suitable for you.
Important information about potentially life-threatening reactions
A small number of people taking Lamictal get an allergic reaction or potentially life-threatening skin
reaction, which may develop into more serious problems if they are not treated. These can include Stevens–
Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) and Drug Reaction with Eosinophilia and
Systemic Symptoms (DRESS). You need to know the symptoms to look out for while you are taking
Lamictal.

2

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

 Read the description of these symptoms in Section 4 of this leaflet under ‘Potentially life-threatening
reactions: get a doctor’s help straight away’.

Thoughts of harming yourself or suicide
Anti-epileptic medicines are used to treat several conditions, including epilepsy and bipolar disorder. People
with bipolar disorder can sometimes have thoughts of harming themselves or committing suicide. If you
have bipolar disorder, you may be more likely to think like this:
• when you first start treatment
• if you have previously had thoughts about harming yourself or about suicide
• if you are under 25 years old.
If you have distressing thoughts or experiences, or if you notice that you feel worse or develop new
symptoms while you’re taking Lamictal:
 See a doctor as soon as possible or go to the nearest hospital for help.
You may find it helpful to tell a family member, caregiver or close friend that you can become
depressed or have significant changes in mood, and ask them to read this leaflet. You might ask them
to tell you if they are worried about your depression or other changes in your behaviour.
A small number of people being treated with anti-epileptics such as Lamictal have also had thoughts of
harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.

If you’re taking Lamictal for epilepsy
The seizures in some types of epilepsy may occasionally become worse or happen more often while you’re
taking Lamictal. Some patients may experience severe seizures, which may cause serious health problems. If
your seizures happen more often or if you experience a severe seizure while you’re taking Lamictal:
 See a doctor as soon as possible.
Lamictal should not be given to people aged under 18 years to treat bipolar disorder. Medicines to
treat depression and other mental health problems increase the risk of suicidal thoughts and behaviour in
children and adolescents aged under 18 years.

Other medicines and Lamictal
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines including herbal medicines or other medicines bought without a prescription.
Your doctor needs to know if you are taking other medicines to treat epilepsy or mental health problems.
This is to make sure you take the correct dose of Lamictal. These medicines include:
• oxcarbazepine, felbamate, gabapentin, levetiracetam, pregabalin, topiramate or zonisamide, used
to treat epilepsy
• lithium, olanzapine or aripiprazole used to treat mental health problems
• bupropion, used to treat mental health problems or to stop smoking
 Tell your doctor if you are taking any of these.
Some medicines interact with Lamictal or make it more likely that people will have side effects. These
include:
• valproate, used to treat epilepsy and mental health problems
• carbamazepine, used to treat epilepsy and mental health problems
• phenytoin, primidone or phenobarbitone, used to treat epilepsy
• risperidone, used to treat mental health problems
• rifampicin, which is an antibiotic
• medicines used to treat Human Immunodeficiency Virus (HIV) infection (a combination of lopinavir
and ritonavir or atazanavir and ritonavir)
3

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

• hormonal contraceptives, such as the Pill (see below).
 Tell your doctor if you are taking any of these or if you start or stop taking any.

Hormonal contraceptives (such as the Pill) can affect the way Lamictal works
Your doctor may recommend that you use a particular type of hormonal contraceptive or another method of
contraception, such as condoms, a cap or coil. If you are using a hormonal contraceptive like the Pill, your
doctor may take samples of your blood to check the level of Lamictal. If you are using a hormonal
contraceptive or if you plan to start using one:
 Talk to your doctor, who will discuss suitable methods of contraception with you.
Lamictal can also affect the way hormonal contraceptives work, although it’s unlikely to make them less
effective. If you are using a hormonal contraceptive and you notice any changes in your menstrual pattern,
such as breakthrough bleeding or spotting between periods:
 Tell your doctor. These may be signs that Lamictal is affecting the way your contraceptive is working.

Pregnancy and breast-feeding
.
 If you are pregnant, think you may be pregnant or are planning to have a baby ask your doctor or
pharmacist for advice before taking this medicine.
• You should not stop treatment without discussing this with your doctor. This is particularly
important if you have epilepsy.
• Pregnancy may alter the effectiveness of Lamictal, so you may need blood tests and your dose of
Lamictal may be adjusted.
• There may be a small increased risk of birth defects, including a cleft lip or cleft palate, if Lamictal is
taken during the first 3 months of pregnancy.
• Your doctor may advise you to take extra folic acid if you’re planning to become pregnant and while
you’re pregnant.
 If you are breast-feeding or planning to breast-feed ask your doctor or pharmacist for advice
before taking this medicine. The active ingredient of Lamictal passes into breast milk and may affect
your baby. Your doctor will discuss the risks and benefits of breast-feeding while you’re taking Lamictal
and will check your baby from time to time if you decide to breast-feed.

Driving and using machines
Lamictal can cause dizziness and double vision.
 Don’t drive or use machines unless you are sure you’re not affected.
If you have epilepsy, talk to your doctor about driving and using machines.

3 How to take Lamictal
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.

How much Lamictal to take
It may take a while to find the best dose of Lamictal for you. The dose you take will depend on:
• your age
• whether you are taking Lamictal with other medicines
• whether you have any kidney or liver problems.

4

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

Your doctor will prescribe a low dose to start and gradually increase the dose over a few weeks until you
reach a dose that works for you (called the effective dose). Never take more Lamictal than your doctor
tells you to.
The usual effective dose of Lamictal for adults and children aged 13 years or over is between 100 mg and
400 mg each day.
For children aged 2 to 12 years, the effective dose depends on their body weight - usually, it’s between 1 mg
and 15 mg for each kilogram of the child’s weight, up to a maximum maintenance dose of 200 mg daily.
Lamictal is not recommended for children aged under 2 years.

How to take your dose of Lamictal
Take your dose of Lamictal once or twice a day, as your doctor advises. It can be taken with or without food.
• Always take the full dose that your doctor has prescribed. Never take only part of a tablet.
Your doctor may also advise you to start or stop taking other medicines, depending on what condition you’re
being treated for and the way you respond to treatment.
Lamictal chewable/dispersible tablets can either be swallowed whole with a little water, chewed or mixed
with water to make a liquid medicine.
To chew the tablet:
You may need to drink a little water at the same time to help the tablet dissolve in the mouth. Then drink
some more water to make sure all the medicine has been swallowed.
To make a liquid medicine:
• Put the tablet in a glass with at least enough water to cover the whole tablet.
• Either stir to dissolve or wait until the tablet is fully dissolved.
• Drink all the liquid.
• Add a little more water to the glass and drink that, to make sure no medicine is left in the glass.

If you take more Lamictal than you should
 Contact a doctor or nearest hospital emergency department immediately. If possible, show them
the Lamictal packet.
If you take too much Lamictal you may be more likely to have serious side effects which may be fatal.
Someone who has taken too much Lamictal may have any of these symptoms:
• rapid, uncontrollable eye movements (nystagmus)
• clumsiness and lack of co-ordination, affecting their balance (ataxia)
• heart rhythm changes (detected usually on ECG)
• loss of consciousness, fits (convulsions) or coma.

If you forget to take a single dose of Lamictal
 Don’t take extra tablets to make up for a missed dose. Just take your next dose at the usual time.
In case you forget to take multiple doses of Lamictal
 Ask your doctor for advice on how to start taking it again. It’s important that you do this.

Don’t stop taking Lamictal without advice
Lamictal must be taken for as long as your doctor recommends. Don’t stop unless your doctor advises you
to.

5

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

If you’re taking Lamictal for epilepsy
To stop taking Lamictal, it is important that the dose is reduced gradually, over about 2 weeks. If you
suddenly stop taking Lamictal, your epilepsy may come back or get worse.

If you’re taking Lamictal for bipolar disorder
Lamictal may take some time to work, so you are unlikely to feel better straight away. If you stop taking
Lamictal, your dose will not need to be reduced gradually but you should still talk to your doctor first, if you
want to stop taking Lamictal.

4 Possible side effects
Like all medicines, this medicine can cause side effects, but not everyone gets them.

Potentially life-threatening reactions: get a doctor’s help straight away
A small number of people taking Lamictal get an allergic reaction or potentially life-threatening skin
reaction, which may develop into more serious problems if they are not treated.
These symptoms are more likely to happen during the first few months of treatment with Lamictal,
especially if the starting dose is too high or if the dose is increased too quickly or if Lamictal is taken with
another medicine called valproate. Some of the symptoms are more common in children, so parents should
be especially careful to watch out for them.
Symptoms of these reactions include:
• skin rashes or redness, which may develop into life-threatening skin reactions including widespread
rash with blisters and peeling skin, particularly occurring around the mouth, nose, eyes and genitals
(Stevens-Johnson syndrome), extensive peeling of the skin (more than 30% of the body surface - toxic
epidermal necrolysis) or extended rashes with liver, blood and other body organs involvement (Drug
Reaction with Eosinophilia and Systemic Symptoms which is also known as DRESS hypersensitivity
syndrome)
• ulcers in the mouth, throat, nose or genitals
• a sore mouth or red or swollen eyes (conjunctivitis)
• a high temperature (fever), flu-like symptoms or drowsiness
• swelling around your face or swollen glands in your neck, armpit or groin
• unexpected bleeding or bruising, or the fingers turning blue
• a sore throat or more infections (such as colds) than usual
• increased levels of liver enzymes seen in blood tests
• an increase in a type of white blood cell (eosinophils)
• enlarged lymph nodes
• involvement of the organs of the body including liver and kidneys.
In many cases, these symptoms will be signs of less serious side effects but you must be aware that they
are potentially life-threatening and can develop into more serious problems, such as organ failure, if
they are not treated. If you notice any of these symptoms:
 Contact a doctor immediately. Your doctor may decide to carry out tests on your liver, kidneys or
blood and may tell you to stop taking Lamictal. In case you have developed Stevens-Johnson syndrome
or toxic epidermal necrolysis your doctor will tell you that you must never use lamotrigine again.

Very common side effects
These may affect more than 1 in 10 people:
• headache
6

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2



skin rash.

Common side effects
These may affect up to 1 in 10 people:
• aggression or irritability
• feeling sleepy or drowsy
• feeling dizzy
• shaking or tremors
• difficulty in sleeping (insomnia)
• feeling agitated
• diarrhoea
• dry mouth
• feeling sick (nausea) or being sick (vomiting)
• feeling tired
• pain in your back or joints, or elsewhere.

Uncommon side effects
These may affect up to 1 in 100 people:
• clumsiness and lack of co-ordination (ataxia)
• double vision or blurred vision
• unusual hair loss or thinning (alopecia).

Rare side effects
These may affect up to 1 in 1,000 people:
• a life-threatening skin reaction (Stevens-Johnson syndrome): (see also the information at the beginning
of Section 4)
• a group of symptoms together including: fever, nausea, vomiting, headache, stiff neck and extreme
sensitivity to bright light. This may be caused by an inflammation of the membranes that cover the brain
and spinal cord (meningitis). These symptoms usually disappear once treatment is stopped however if
the symptoms continue or get worse contact your doctor
• rapid, uncontrollable eye movements (nystagmus)
• itchy eyes, with discharge and crusty eyelids (conjunctivitis).

Very rare side effects
These may affect up to 1 in 10,000 people:
• a life-threatening skin reaction (toxic epidermal necrolysis): (see also the information at the beginning
of Section 4)
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): (see also the information at the
beginning of Section 4)
• a high temperature (fever): (see also the information at the beginning of Section 4)
• swelling around the face (oedema) or swollen glands in the neck, armpit or groin (lymphadenopathy):
(see also the information at the beginning of Section 4)
• changes in liver function, which will show up in blood tests or liver failure: (see also the information at
the beginning of Section 4)
• a serious disorder of blood clotting, which can cause unexpected bleeding or bruising (disseminated
intravascular coagulation): (see also the information at the beginning of Section 4)
• changes which may show up in blood tests - including reduced numbers of red blood cells (anaemia),
reduced numbers of white blood cells (leucopenia, neutropenia, agranulocytosis), reduced numbers of
platelets (thrombocytopenia), reduced numbers of all these types of cell (pancytopenia) and a disorder
of the bone marrow called aplastic anaemia
7

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2









hallucinations (‘seeing’ or ‘hearing’ things that aren’t really there)
confusion
feeling ‘wobbly’ or unsteady when you move about
uncontrollable body movements (tics), uncontrollable muscle spasms affecting the eyes, head and torso
(choreoathetosis) or other unusual body movements such as jerking, shaking or stiffness
in people who already have epilepsy, seizures happening more often
in people who already have Parkinson’s disease, worsening of the symptoms.
lupus-like reaction (symptoms may include: back or joint pain which sometimes may be accompanied by
fever and/or general ill health).

Other side effects
Other side effects have occurred in a small number of people but their exact frequency is unknown:
• There have been reports of bone disorders including osteopenia and osteoporosis (thinning of the bone)
and fractures. Check with your doctor or pharmacist if you are on long-term anti-epileptic medication,
have a history of osteoporosis or take steroids
• Nightmares.

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Lamictal
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date shown on the blisters, carton or bottle. The expiry date refers
to the last day of that month.
Lamictal does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use. This will help protect the environment.

6 Contents of the pack and other information
What Lamictal chewable/dispersible tablets contain
The active substance is lamotrigine. Each chewable/dispersible tablet contains 50 mg or 200 mg lamotrigine.
The other ingredients are: calcium carbonate, low substituted hydroxypropyl cellulose, aluminium
magnesium silicate, sodium starch glycolate (Type A), povidone K30, saccharin sodium, magnesium
stearate, blackcurrant flavour.

What Lamictal chewable/dispersible tablets look like and contents of the pack
Lamictal chewable/dispersible tablets (all strengths) are white to off-white and may be slightly mottled.
They smell of blackcurrant. Not all listed pack sizes are marketed.

8

Reason for update: GDS 42-WS158-alopecia
Text Date: 10/03/2016
MHRA Approval:
Text Issue and Draft No.: Issue 9
Draft 2

Lamictal 50 mg chewable/dispersible tablets are square with rounded corners. They are marked ‘GSCX7’ on
one side; and ‘50’ on the other. Each pack contains blisters of 10, 14, 28, 30, 42, 50, 56, 60, 90, 98, 100, 196
or 200 tablets.
Lamictal 200 mg chewable/dispersible tablets are square with rounded corners. They are marked ‘GSEC5’
on one side; and ‘200’ on the other. Each pack contains blisters of 10, 14, 28, 30, 42, 50, 56, 60, 90, 98, 100,
196 or 200 tablets.

Marketing authorisation holder and manufacturer
Marketing Authorisation Holder: The Wellcome Foundation Ltd., Stockley Park West, Uxbridge, Middlesex
UB11 1BT
Manufacturer: GlaxoSmithKline Pharmaceuticals S.A., Ul. Grunwaldzka 189, 60-322 Poznań, Poland
This leaflet was last revised in: March 2016
Lamictal is a registered trade mark of the GSK group of companies
© 2016 GSK group of companies. All rights reserved

9

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide